Related Experiment Videos
Cellular receptors and hantavirus pathogenesis
E R Mackow1, I N Gavrilovskaya
1Department of Medicine, Stony Brook University, HSC T17, Room 60, Stony Brook, NY 11794, USA.
Current Topics in Microbiology and Immunology
|February 24, 2001
Summary
Hantaviruses exploit human beta 3 integrins on platelets and endothelial cells, causing severe diseases like HPS and HFRS. Developing therapies targeting this interaction is crucial for future treatment and prevention.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Hantaviruses cause severe diseases, hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS).
- Both HPS and HFRS are characterized by vascular permeability defects and impaired platelet function.
- Human beta 3 integrins are cellular receptors critical for maintaining capillary integrity and regulating platelet activity.
Purpose of the Study:
- To explore the role of human beta 3 integrins in hantavirus pathogenesis.
- To investigate how hantaviruses interact with cellular receptors, specifically beta 3 integrins.
- To identify potential therapeutic targets for hantavirus diseases.
Main Methods:
- Analysis of hantavirus surface glycoproteins (G1 and G2) and their interaction with cellular receptors.
- Review of existing literature on beta 3 integrin function in platelets and endothelial cells.
- Discussion of potential roles for unstudied factors like vitronectin and complement cascades.
Main Results:
- Human beta 3 integrins are identified as cellular receptors conferring susceptibility to hantaviruses.
- Hantavirus interaction with beta 3 integrins directly links platelets, endothelial cells, and disease pathogenesis.
- Variation in hantavirus glycoproteins likely influences specific pathogenic responses and cellular interactions.
Conclusions:
- Hantavirus exploitation of beta 3 integrins is fundamental to disease pathogenesis.
- Understanding these interactions may lead to novel therapeutic interventions and vaccine development.
- Transgenic mouse models using human beta 3 integrins show promise for studying hantavirus disease.